相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Gerhard Hindricks et al.
EUROPEAN HEART JOURNAL (2021)
A review of global health technology assessments of non-VKA oral anticoagulants in non-valvular atrial fibrillation
Renato D. Lopes et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2020)
Apixaban for Stroke Prevention in Atrial Fibrillation: Why are Event Rates Higher in Clinical Practice than in Randomized Trials?-A Systematic Review
Tim A. C. de Vries et al.
THROMBOSIS AND HAEMOSTASIS (2020)
Cost-effectiveness of direct oral anticoagulants versus vitamin K antagonist in atrial fibrillation A study protocol using Real-World Data from Catalonia (FantasTIC Study)
Zojaina Hernandez Rojas et al.
MEDICINE (2020)
Patient characteristics and stroke and bleeding events in nonvalvular atrial fibrillation patients treated with apixaban and vitamin K antagonists: a Spanish real-world study
Sreeram Ramagopalan et al.
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2019)
Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with vitamin K antagonists in patients with nonvalvular atrial fibrillation: a systematic literature review
Jean-Baptiste Briere et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2019)
PCV23 CLINICAL AND ECONOMIC IMPACT OF NON-VKA ANTICOAGULANTS INCREASED USE IN THE TREATMENT OF NONVALVULAR ATRIAL FIBRILLATION IN SPAIN BASED ON REAL-LIFE DATA
C. Escobar Cervantes et al.
VALUE IN HEALTH (2019)
PMU146 VALIDATION AND REPRESENTATIVENESS OF THE SPANISH BIG-PAC DATABASE: INTEGRATED COMPUTERIZED MEDICAL RECORDS FOR RESEARCH INTO EPIDEMIOLOGY, MEDICINES AND HEALTH RESOURCE USE (REAL WORD EVIDENCE)
A. Sicras-Mainar et al.
VALUE IN HEALTH (2019)
Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation
Brandon K. Martinez et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, or rivaroxaban
Ping G. Tepper et al.
PLOS ONE (2018)
Cost-effectiveness analysis of apixaban versus acetylsalicylic acid in the prevention of stroke in patients with non-valvular atrial fibrillation in Spain
Gines Escolar-Albaladejo et al.
ATENCION PRIMARIA (2016)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Paulus Kirchhof et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2016)
Comparison of treatment effect estimates of non-vitamin K antagonist oral anticoagulants versus warfarin between observational studies using propensity score methods and randomized controlled trials
Guowei Li et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2016)
A tailored treatment strategy: a modern approach for stroke prevention in patients with atrial fibrillation
G. Y. H. Lip et al.
JOURNAL OF INTERNAL MEDICINE (2016)
A Systematic Literature Review on the Cost-Effectiveness of Apixaban for Stroke Prevention in Non-valvular Atrial Fibrillation
Carme Pinyol et al.
CARDIOLOGY AND THERAPY (2016)
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society
Craig T. January et al.
CIRCULATION (2014)
Stroke and Bleeding Risk in Atrial Fibrillation: Navigating the Alphabet Soup of Risk-Score Acronyms (CHADS2, CHA2DS2-VASc, R2CHADS2, HAS-BLED, ATRIA, and More)
Mikhail S. Dzeshka et al.
CLINICAL CARDIOLOGY (2014)
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Christian T. Ruff et al.
LANCET (2014)
Prevalencia de fibrilación auricular en España. Resultados del estudio OFRECE
Juan José Gómez-Doblas et al.
REVISTA ESPANOLA DE CARDIOLOGIA (2013)
分享论文
